Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TAMIFLU 6 MG/ML SUSPENSION

Oseltamivir Phosphate
$2.4329per ML
High Outlier

Strength

6 mg/mL

Manufacturer

Genentech, Inc.

NDC

00004082205

Classification

Brand

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

New Drug (NDA)

FDA Application

NDA021246

On Market Since

3/21/2011

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.1%

1Y

+0.1%

3Y

-0.3%

5Y

-0.0%

All

+42.9%

Generic Alternatives

Save up to 94%

5 alternatives • Same active ingredient

OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
47781038426•Alvogen Inc.
$0.1548
Save 94%
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
69238127306•Amneal Pharmaceuticals NY LLC
$0.1548
Save 94%
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
68180067801•Lupin Pharmaceuticals Inc.
$0.1548
Save 94%
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
64380087975•Strides Pharma Inc.
$0.1548
Save 94%
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
00093818064•Teva Pharmaceuticals USA Inc.
$0.1548
Save 94%

Related Drugs

Same classification

RELENZA 5 MG DISKHALER
Brand
00173068101•GlaxoSmithKline LLC
$2.8319
per EA
TAMIFLU 30 MG CAPSULE
Brand
00004080285•Genentech, Inc.
$13.3994
per EA
TAMIFLU 45 MG CAPSULE
Brand
00004080185•Genentech, Inc.
$13.5402
per EA
TAMIFLU 75 MG CAPSULE
Brand
00004080085•Genentech, Inc.
$14.5186
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy